Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 419

Sort by

Sort Order Select

Journal Articles

FV/FVa revealed

Josefin Ahnström

Blood (2021) 137 (22): 3011–3013.

https://doi.org/10.1182/blood.2021011573

Published: 2021

Journal Articles

Identification of a Spontaneous Noncoding Mutation on Chromosome 18 Which Suppresses Thrombosis in Factor V Leiden Homozygous, TFPI Deficient Mice

Marisa A Brake, BSc, McKenzie A Allen, BSc, Guojing Zhu, MD, Amy E Siebert, PhD, Randal J Westrick, PhD

Blood (2019) 134 (Supplement_1): 483.

https://doi.org/10.1182/blood-2019-130936

Published: 2019

Journal Articles

Thrombophilia Testing in Hospitalized Patients with Acute Ischemic Stroke: An Opportunity for Hematology Input

Jori May, MD, Chen Lin, MD, Kimberly Martin, PhD, Laura J Taylor, M.T., Radhika Gangaraju, MD

Blood (2019) 134 (Supplement_1): 2105.

https://doi.org/10.1182/blood-2019-122615

Published: 2019

Journal Articles

Thrombotic Outcomes Following Hormonal Treatment of Heavy Menstrual Bleeding in Pediatric Patients Taking Anticoagulation

Michael H. White, MD, Gary Woods, MD, Robert F. Sidonio, Jr., MD MSc

Blood (2019) 134 (Supplement_1): 2179.

https://doi.org/10.1182/blood-2019-130100

Published: 2019

Journal Articles

Utility of Thrombophilia Testing in Portal Vein Thrombosis in a Large Single Institutional Cohort

Douglas Tremblay, MD, Leonard Naymagon, MD, Kevin Troy, MD, Caroline Cromwell, MD, Colleen Edwards, MD, Thomas Schiano, MD, Marina Kremyanskaya, John Mascarenhas, MD

Blood (2019) 134 (Supplement_1): 3646.

https://doi.org/10.1182/blood-2019-123651

Published: 2019

Journal Articles

Patients with Familial Thrombophilia of Unknown Origin Show Low APC Response to In Vivo Thrombin Formation in Stimulated Hemostasis Activity Pattern Evaluation (SHAPE)

Heiko Rühl, MD, Sara Reda, MD, Franziska Isabelle Winterhagen, Christina Berens, MD, Jens Müller, Johannes Oldenburg, Bernd Pötzsch, MD

Blood (2019) 134 (Supplement_1): 3647.

https://doi.org/10.1182/blood-2019-124507

Published: 2019

Journal Articles

Risk Factors, Clinical Manifestations, Treatment Duration and Outcomes in Carriers of Severe Inherited Thrombophilias

Ivan Bascon, Molecular Bioscience and Biotechnology, B.S., Paul J Christos, Dr.P.H., M.S., Maria Teresa De Sancho, MD MSc

Blood (2019) 134 (Supplement_1): 3657.

https://doi.org/10.1182/blood-2019-132248

Published: 2019

Journal Articles

High Frequencies of Mutated EZH2 and IRF8 and Other Epigenetic Genes in Primary Bone Lymphomas Are Indicative of GCB-Phenotype

Blood (2019) 134 (Supplement_1): 1484.

https://doi.org/10.1182/blood-2019-129832

Published: 2019

Journal Articles

One- Week Prophylaxis with Enoxaparin after Hospital Discharge Is Effective in Preventing Venous Thromboembolism in Living Liver Donors- Single Institution Retrospective Analysis

Leila Khaddour, MD, Zaid Al Saheli, MD, Yaser Alkhatib, MD, Marwan Abouljoud, MD, Philip Kuriakose, MD

Blood (2019) 134 (Supplement_1): 2442.

https://doi.org/10.1182/blood-2019-124169

Published: 2019

Journal Articles

A Pilot Study of an Oral Anticoagulant, Apixaban, in Secondary Prophylaxis of Venous Thromboembolism (VTE) in Children and Adolescents

Ashley Pinchinat, MD, Neida Otero, Harshini Mahanti, BS, MSCR, Erin Morris, RN, BSN, Adele Brudnicki, MD, Deborah Friedman, MD, Simon Li, MD, Oya Levendoglu-Tugal, MD, Mitchell S Cairo, MD

Blood (2019) 134 (Supplement_1): 2443.

https://doi.org/10.1182/blood-2019-130468

Published: 2019

Journal Articles

Animal Models Demonstrate a Critical Role of Factor VIII in Par4- and Platelet-Mediated Pathology

Michelle Castillo, BS, Quihui Yang, MD PhD, Dosia McKinney, Qizhen Shi, MD PhD, Rashmi Sood, PhD

Blood (2019) 134 (Supplement_1): 1057.

https://doi.org/10.1182/blood-2019-123290

Published: 2019

Journal Articles

In Vivo hemostatic Significance of Activated Protein C in Factor VIIIa Regulation

Amelia R. Wilhelm, B.S., Nicole A. Parsons, B.S., Charles T. Esmon, PhD, Rodney M. Camire, PhD, Lindsey A. George, MD

Blood (2019) 134 (Supplement_1): 93.

https://doi.org/10.1182/blood-2019-124493

Published: 2019

Journal Articles

Factor V Leiden Testing and Its Effects on Decision-Making: An Institutional Survey

Tushar Pawar, MD MPH, Ian Garrahy, DO, Anthony Donato, MD MHPE, Amber Stevenson, CMA, Daniel Forman, DO

Blood (2019) 134 (Supplement_1): 4977.

https://doi.org/10.1182/blood-2019-131427

Published: 2019

Journal Articles

An Institutional Survey of Thrombophilia Evaluation in the Setting of Venous Thromboembolism (VTE)

Ian Garrahy, DO, Tushar Pawar, MD MPH, Anthony Donato, MD, Amber Stevenson, CMA, Daniel Forman, DO

Blood (2019) 134 (Supplement_1): 4956.

https://doi.org/10.1182/blood-2019-128908

Published: 2019

Journal Articles

Facing Deep Venous Thrombosis (DVT) in University Tertiary Hospital: Role of Conventional Thrombophilia Testing in Idiopathic DVT Treatment

Milagros Suito, MD, Maria Cerdá, MD, Olga Benítez, MD, Alba Cabirta, MD, Francesc Bosch, MD PhD, Amparo Santamaria, MD PhD

Blood (2019) 134 (Supplement_1): 4958.

https://doi.org/10.1182/blood-2019-132042

Published: 2019

Journal Articles

Assessment and Reduction of Unnecessary Thrombophilia Testing in Patients 18-60 Years with Acute Cryptogenic Ischemic Stroke

Effrosyni Apostolidou, MD, PhD, Masumeh Hatami, MD, Sean.I. Savitz, MD, Eric Thomas, MD, Priya Khatri, MBA, MPH, Alicia Zha, MD

Blood (2019) 134 (Supplement_1): 3397.

https://doi.org/10.1182/blood-2019-124521

Published: 2019

Journal Articles

Effects of Actr2 gene Variants on Mouse Viability, Gene Expression, and Cytoskeletal Dynamics

Linzi M Hobbs, BS, Amy E Siebert, PhD, Alexander J Johnston, BS, Marisa A Brake, BSc, Vakharia Paras, PharmD, MD, Cleuren Audrey, PhD, Guojing Zhu, MD, Randal J Westrick, PhD

Blood (2019) 134 (Supplement_1): 2340.

https://doi.org/10.1182/blood-2019-131004

Published: 2019

Journal Articles

Mitigation of Venous Thromboembolism Risk through Favorable Lifestyle: The ARIC Study

Christina Evans, MPH,MD, Ching-Png Hong, Aaron R Folsom, MD, Susan Heckbert, MD PhD, Nicholas Smith, PhD, Kerri Wiggins, MS, Mary Cushman, MD

Blood (2019) 134 (Supplement_1): 1151.

https://doi.org/10.1182/blood-2019-131290

Published: 2019

Journal Articles

Bleeding in Mild Hemophilia A Due to a Splice-Site F8 Mutation May be Fully Abrogated By Prothrombotic Gene Variants

Peter H. Cygan, MD, Sarah E. Arnold-Croop, MS, Elizabeth A. Weidman, BS, Fang Chen, PhD, Dajiang J. Liu, PhD, M. Elaine Eyster, MD, Laura Carrel, PhD

Blood (2019) 134 (Supplement_1): 1125.

https://doi.org/10.1182/blood-2019-126026

Published: 2019

Journal Articles

Elevated Von Willebrand Factor May Abrogate Bleeding Phenotype in a Male with a Non-Null F8 Mutation

Peter H. Cygan, MD, Sarah E. Arnold-Croop, MS, Elizabeth A. Weidman, BS, Laura Carrel, PhD, M. Elaine Eyster, MD

Blood (2018) 132 (Supplement 1): 3787.

https://doi.org/10.1182/blood-2018-99-116905

Published: 2018

NARROW

FV/FVa revealed

Identification of a Spontaneous Noncoding Mutation on Chromosome 18 Which Suppresses Thrombosis in Factor V Leiden Homozygous, TFPI Deficient Mice

Thrombophilia Testing in Hospitalized Patients with Acute Ischemic Stroke: An Opportunity for Hematology Input

Thrombotic Outcomes Following Hormonal Treatment of Heavy Menstrual Bleeding in Pediatric Patients Taking Anticoagulation

Utility of Thrombophilia Testing in Portal Vein Thrombosis in a Large Single Institutional Cohort

Patients with Familial Thrombophilia of Unknown Origin Show Low APC Response to In Vivo Thrombin Formation in Stimulated Hemostasis Activity Pattern Evaluation (SHAPE)

Risk Factors, Clinical Manifestations, Treatment Duration and Outcomes in Carriers of Severe Inherited Thrombophilias

High Frequencies of Mutated EZH2 and IRF8 and Other Epigenetic Genes in Primary Bone Lymphomas Are Indicative of GCB-Phenotype

One- Week Prophylaxis with Enoxaparin after Hospital Discharge Is Effective in Preventing Venous Thromboembolism in Living Liver Donors- Single Institution Retrospective Analysis

A Pilot Study of an Oral Anticoagulant, Apixaban, in Secondary Prophylaxis of Venous Thromboembolism (VTE) in Children and Adolescents

Animal Models Demonstrate a Critical Role of Factor VIII in Par4- and Platelet-Mediated Pathology

In Vivo hemostatic Significance of Activated Protein C in Factor VIIIa Regulation

Factor V Leiden Testing and Its Effects on Decision-Making: An Institutional Survey

An Institutional Survey of Thrombophilia Evaluation in the Setting of Venous Thromboembolism (VTE)

Facing Deep Venous Thrombosis (DVT) in University Tertiary Hospital: Role of Conventional Thrombophilia Testing in Idiopathic DVT Treatment

Assessment and Reduction of Unnecessary Thrombophilia Testing in Patients 18-60 Years with Acute Cryptogenic Ischemic Stroke

Effects of Actr2 gene Variants on Mouse Viability, Gene Expression, and Cytoskeletal Dynamics

Mitigation of Venous Thromboembolism Risk through Favorable Lifestyle: The ARIC Study

Bleeding in Mild Hemophilia A Due to a Splice-Site F8 Mutation May be Fully Abrogated By Prothrombotic Gene Variants

Elevated Von Willebrand Factor May Abrogate Bleeding Phenotype in a Male with a Non-Null F8 Mutation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only